What We're Reading: Page
Industry reads hand-picked by our editors
Jan 23, 2018
-
Financial Times
Big pharma makes strongest start to M&A for a decade
-
Xconomy
Tmunity reels in $100M for “next generation” cancer immunotherapy
-
The Wall Street Journal
China, unhampered by rules, races ahead in gene-editing trials
Jan 22, 2018
Jan 19, 2018
-
Los Angeles Times
We're underfunding research on vaccines that may be able to prevent another terrible flu season
-
CNBC
This start-up founder has a novel strategy for getting ahead: Telling the truth
-
Business Insider
'We're not going to follow the hype': Biotech VCs are concerned by the staggering size of early-stage startup funding
Jan 18, 2018
-
The Wall Street Journal
Judge signals he will approve $290 million settlement between Allergan shareholders and Pershing, Valeant
-
MIT Technology Review
U.S. doctors plan to treat cancer patients using CRISPR
-
Healthcare Dive
Study finds limited evidence that remote patient monitoring improves outcomes
-
Politico
Senate committee advances Trump's nominee for HHS secretary
-
Retail Dive
Walmart to give away opioid disposal kits
Jan 17, 2018
-
The Wall Street Journal
Celgene in talks to buy Juno Therapeutics
-
Bloomberg
Biotech ETF leaks cash as hopes for more M&A fizzle
-
Nature
Biotech booms in China
Jan 16, 2018
-
Reuters
Google venture arm backs UK universal flu vaccine company
-
Financial Times
Big pharma efforts on Alzheimer’s tested by Pfizer exit
-
The Wall Street Journal
Don’t fear a biotech correction
-
NPR
For now, sequencing cancer tumors holds more promise than proof
Previous
